Rating History for Teva Pharma (TEVA) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/25/2023 | Thibault Boutherin | New Coverage | Equalweight (N/A) |
10.00 (N/A) |
7.57 (37.34) |
393.26% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/25/2023 | Thibault Boutherin | New Coverage | Equalweight (N/A) |
10.00 (N/A) |
7.57 (37.34) |
393.26% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||